FDA data Registry peer set 3 peers

Alternatives to saxagliptin

3 same-class SPL records vs saxagliptin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

View saxagliptin → All alternatives

Brand: Onglyza

DPP-4 Inhibitor Prescription 3 alternatives found

About saxagliptin

View full saxagliptin profile →

3 DPP-4 Inhibitor peers (wide set)

alogliptin

Rx

Nesina

linagliptin

Rx

Tradjenta

sitagliptin

Rx

Januvia

Compare saxagliptin vs alogliptin side-by-side →

saxagliptin vs alogliptin & linagliptin · FAERS reaction fields

FAERS top-reaction field "Blood Glucose Increased" shows the widest count spread between saxagliptin and alogliptin, linagliptin, sitagliptin in this extract (4,052-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect saxagliptin alogliptinlinagliptinsitagliptin
Cardiac Failure Congestive 428 - - -
Blood Glucose Increased 401 86 1,326 4,453
Cardiac Failure 400 - - -
Nausea 372 124 1,138 3,790
Diarrhoea 328 134 1,196 3,470
Fatigue 261 71 1,028 2,885
Dizziness 260 77 919 2,435
Headache 253 - 745 2,508

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

saxagliptin peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for DPP-4 Inhibitor: 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside saxagliptin? ▼
This registry lists 3 DPP-4 Inhibitor medication records beside saxagliptin, including alogliptin, linagliptin, sitagliptin. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide DPP-4 Inhibitor peer set (3 records)

saxagliptin (Onglyza) sits in a wide DPP-4 Inhibitor peer set (3 of 3 class peers shown).

Top FAERS reaction fields for saxagliptin total 3,180 reports across 10 reactions, set beside alogliptin, linagliptin, sitagliptin. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full saxagliptin profile →

Field note for saxagliptin: see also the generic vs brand label guide when reading Onglyza SPL strings.

Read our methodology - how this data is sourced, computed, and verified.